Matches in SemOpenAlex for { <https://semopenalex.org/work/W2909654314> ?p ?o ?g. }
Showing items 1 to 79 of
79
with 100 items per page.
- W2909654314 endingPage "3966" @default.
- W2909654314 startingPage "3966" @default.
- W2909654314 abstract "Abstract Background : Despite the growing knowledge about acute myeloid leukemia (AML) pathophysiology, it remains a disease with high mortality rates, and the early recognition of patients at higher risk allows adjusted risk- or target-specific therapies. In AML, autocrine insulin like growth factor type 1 (IGF1) and its receptor (IGF1R) activation has been previously described. Free IGF mediate cellular functions through binding to the two IGF receptors, IGF1R and IGF2R. IGF2R binds to and induces degradation of IGF2, preventing IGF2-IGF1R signaling activation, IGF1R activation induces cell proliferation and prevents cell death. Therefore, IGF2R may act as a tumor suppressor and IGF1R has opposite effects. IGF1R pharmacological inhibitors have recently been investigated in the clinical setting for solid tumors, but still underexplored in hematological neoplasms. Aims : To investigate IGF1R and IGF2R mRNA expression in primary samples from AML patients and their impact in clinical outcomes, and to analyze the effects of the IGF1R pharmacological inhibitor linsitinib in AML cell lines. Material and methods : IGF1R and IGF2R mRNA expression levels in AML patients (n=172) were obtained from TCGA AML study (2013) available online on CBioPortal for Cancer Genomics (Cerami et al. 2012; Gao et al. 2013). Gene expression was investigated, by qPCR, in a subset AML cohort (n=101; APL=48, CBF-leukemia=53 [t(8;21)=30, Inv16=23]), and in total bone marrow samples from healthy donors (HD) (n=23). The study was approved by the ethics committee of the Institution. NB4, NB4-R2 and Kasumi-1 cell lines were submitted to linsitinib (0.25, 0.5, 1.0, 2.5, 5.0, 10, 20 or 40 µM) for 72 hours and were evaluated for cell viability (MTT assay), apoptosis (Annexin V/PI), autophagy (acridine orange staining), and protein expression/activation (western blot). Statistical analyses were performed using Student's t-test, Mann-Whitney test, Kruskal-wallis test and Spearman correlation test, as appropriate. For survival analysis, Kaplan-Meyer curves were compared with log-rank test and cox regression analyzes were applied. Results :Patients were dichotomized according to the median IGF1R and IGF2R expression values, and the IGF1R / IGF2R ratio was calculated by division of absolute number of reads coming from RNA-seq data. Patients with high IGF1R / IGF2R showed poorer overall survival (OS) (29% vs. 56%, P Disclosures No relevant conflicts of interest to declare." @default.
- W2909654314 created "2019-01-25" @default.
- W2909654314 creator A5001416697 @default.
- W2909654314 creator A5002676349 @default.
- W2909654314 creator A5015796272 @default.
- W2909654314 creator A5055033739 @default.
- W2909654314 creator A5064776451 @default.
- W2909654314 creator A5086447272 @default.
- W2909654314 creator A5090660802 @default.
- W2909654314 date "2017-12-07" @default.
- W2909654314 modified "2023-09-29" @default.
- W2909654314 title "IGF signaling predicts outcomes and is a promising target therapy for acute myeloid leukemia" @default.
- W2909654314 doi "https://doi.org/10.1182/blood.v130.suppl_1.3966.3966" @default.
- W2909654314 hasPublicationYear "2017" @default.
- W2909654314 type Work @default.
- W2909654314 sameAs 2909654314 @default.
- W2909654314 citedByCount "0" @default.
- W2909654314 crossrefType "journal-article" @default.
- W2909654314 hasAuthorship W2909654314A5001416697 @default.
- W2909654314 hasAuthorship W2909654314A5002676349 @default.
- W2909654314 hasAuthorship W2909654314A5015796272 @default.
- W2909654314 hasAuthorship W2909654314A5055033739 @default.
- W2909654314 hasAuthorship W2909654314A5064776451 @default.
- W2909654314 hasAuthorship W2909654314A5086447272 @default.
- W2909654314 hasAuthorship W2909654314A5090660802 @default.
- W2909654314 hasConcept C126322002 @default.
- W2909654314 hasConcept C143998085 @default.
- W2909654314 hasConcept C144174609 @default.
- W2909654314 hasConcept C170493617 @default.
- W2909654314 hasConcept C203014093 @default.
- W2909654314 hasConcept C21936154 @default.
- W2909654314 hasConcept C2775960820 @default.
- W2909654314 hasConcept C2778461978 @default.
- W2909654314 hasConcept C2778729363 @default.
- W2909654314 hasConcept C2779282312 @default.
- W2909654314 hasConcept C502942594 @default.
- W2909654314 hasConcept C71924100 @default.
- W2909654314 hasConceptScore W2909654314C126322002 @default.
- W2909654314 hasConceptScore W2909654314C143998085 @default.
- W2909654314 hasConceptScore W2909654314C144174609 @default.
- W2909654314 hasConceptScore W2909654314C170493617 @default.
- W2909654314 hasConceptScore W2909654314C203014093 @default.
- W2909654314 hasConceptScore W2909654314C21936154 @default.
- W2909654314 hasConceptScore W2909654314C2775960820 @default.
- W2909654314 hasConceptScore W2909654314C2778461978 @default.
- W2909654314 hasConceptScore W2909654314C2778729363 @default.
- W2909654314 hasConceptScore W2909654314C2779282312 @default.
- W2909654314 hasConceptScore W2909654314C502942594 @default.
- W2909654314 hasConceptScore W2909654314C71924100 @default.
- W2909654314 hasLocation W29096543141 @default.
- W2909654314 hasOpenAccess W2909654314 @default.
- W2909654314 hasPrimaryLocation W29096543141 @default.
- W2909654314 hasRelatedWork W1560640024 @default.
- W2909654314 hasRelatedWork W1966738468 @default.
- W2909654314 hasRelatedWork W1974246271 @default.
- W2909654314 hasRelatedWork W1996623338 @default.
- W2909654314 hasRelatedWork W2008268901 @default.
- W2909654314 hasRelatedWork W2037652650 @default.
- W2909654314 hasRelatedWork W2059239345 @default.
- W2909654314 hasRelatedWork W2059264164 @default.
- W2909654314 hasRelatedWork W2064359007 @default.
- W2909654314 hasRelatedWork W2075206450 @default.
- W2909654314 hasRelatedWork W2111792530 @default.
- W2909654314 hasRelatedWork W2127931431 @default.
- W2909654314 hasRelatedWork W2247613404 @default.
- W2909654314 hasRelatedWork W2304456342 @default.
- W2909654314 hasRelatedWork W2363815212 @default.
- W2909654314 hasRelatedWork W2442403065 @default.
- W2909654314 hasRelatedWork W2495509417 @default.
- W2909654314 hasRelatedWork W2597974013 @default.
- W2909654314 hasRelatedWork W2938867425 @default.
- W2909654314 hasRelatedWork W3213894810 @default.
- W2909654314 hasVolume "130" @default.
- W2909654314 isParatext "false" @default.
- W2909654314 isRetracted "false" @default.
- W2909654314 magId "2909654314" @default.
- W2909654314 workType "article" @default.